fluoxetine has been researched along with Hyperactivity, Motor in 8 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the ability of Rosmarinus officinalis hydroalcoholic extract (ROHE), as compared to the positive control fluoxetine, to reverse behavioral (hyperactivity, anhedonic behavior and learning deficit in water maze) and biochemical alterations (serum glucose level and acetylcholinesterase, AChE, activity) induced by an animal model of depression, the olfactory bulbectomy (OB) in mice." | 3.78 | Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice. ( Balen, GO; Bettio, LE; Brocardo, PS; Colla, AR; Cunha, MP; Dalmarco, JB; Grando, J; Machado, DG; Neis, VB; Pizzolatti, MG; Prediger, RD; Rial, D; Rodrigues, AL, 2012) |
| " They also had mature onset obesity characterized by a dramatic 80-150% increase in body weight, increased linear growth, and elevated serum levels of leptin, insulin, glucose, and cholesterol." | 3.71 | Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. ( Bates, B; Fan, G; Fekete, C; Jaenisch, R; Kelly, J; Kuehn, R; Lechan, RM; Rios, M, 2001) |
| "Tianeptine (TIA) is an antidepressant drug which enhances the reuptake of serotonin but, in contrast to tricyclics, shows no affinity for neurotransmitter receptors." | 1.31 | Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system. ( Dlaboga, D; Dziedzicka-Wasylewska, M; Maj, J; Rogóz, Z; Skuza, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maximino, C | 1 |
| Puty, B | 1 |
| Benzecry, R | 1 |
| Araújo, J | 1 |
| Lima, MG | 1 |
| de Jesus Oliveira Batista, E | 1 |
| Renata de Matos Oliveira, K | 1 |
| Crespo-Lopez, ME | 1 |
| Herculano, AM | 1 |
| Machado, DG | 2 |
| Cunha, MP | 1 |
| Neis, VB | 2 |
| Balen, GO | 2 |
| Colla, AR | 1 |
| Grando, J | 1 |
| Brocardo, PS | 1 |
| Bettio, LE | 1 |
| Dalmarco, JB | 1 |
| Rial, D | 1 |
| Prediger, RD | 1 |
| Pizzolatti, MG | 1 |
| Rodrigues, AL | 2 |
| Freitas, AE | 1 |
| Budni, J | 1 |
| Lopes, MW | 1 |
| de Souza, LF | 1 |
| Dafre, AL | 1 |
| Leal, RB | 1 |
| Mahesh, R | 1 |
| Rajkumar, R | 1 |
| Minasri, B | 1 |
| Venkatesha Perumal, R | 1 |
| Gainetdinov, RR | 1 |
| Wetsel, WC | 1 |
| Jones, SR | 1 |
| Levin, ED | 1 |
| Jaber, M | 1 |
| Caron, MG | 1 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Dlaboga, D | 1 |
| Maj, J | 1 |
| Dziedzicka-Wasylewska, M | 1 |
| Rios, M | 1 |
| Fan, G | 1 |
| Fekete, C | 1 |
| Kelly, J | 1 |
| Bates, B | 1 |
| Kuehn, R | 1 |
| Lechan, RM | 1 |
| Jaenisch, R | 1 |
| Rhodes, JS | 1 |
| Hosack, GR | 1 |
| Girard, I | 1 |
| Kelley, AE | 1 |
| Mitchell, GS | 1 |
| Garland, T | 1 |
1 trial available for fluoxetine and Hyperactivity, Motor
| Article | Year |
|---|---|
Differential sensitivity to acute administration of cocaine, GBR 12909, and fluoxetine in mice selectively bred for hyperactive wheel-running behavior.
Topics: Animals; Animals, Outbred Strains; Breeding; Cocaine; Crosses, Genetic; Dopamine Uptake Inhibitors; | 2001 |
7 other studies available for fluoxetine and Hyperactivity, Motor
| Article | Year |
|---|---|
Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Buspirone; Disease Models, Animal; D | 2013 |
Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.
Topics: Acetylcholinesterase; Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Depression; E | 2012 |
Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.
Topics: Analysis of Variance; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Brain-Derived Ne | 2013 |
Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 2007 |
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Carrier Proteins; Central | 1999 |
Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aggression; Animals; Binding, Competitive; | 2001 |
Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity.
Topics: Animals; Anxiety; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Fasting; Fluoxetine; Gene D | 2001 |